AMRN: 阿玛琳

AMRN新闻

• 15:59 AstraZeneca Gets FDA Nod for New Hypertension Drug Baxfendy
• 14:58 Roche's Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer
• 16:08 Keros Q1 Loss Wider Than Expected, Revenues Plunge Year Over Year
• 14:11 CRMD Q1 Earnings Beat on DefenCath Momentum, Guidance Raised
• 14:44 ESPR Stock Surges 44% in a Month: Here's What You Need to Know
• 14:42 Altimmune's Q1 Loss Narrower Than Expected, Revenues Nil
• 14:17 Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q1
• 15:23 Dr. Reddy's Q4 Earnings and Revenues Miss Estimates, Stock Down
• 15:21 Agios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell Disease
• 15:44 NTLA Q1 Earnings Beat Estimates, Revenues Miss Mark, Pipeline in Focus
• 15:24 Bayer Q1 Earnings Beat Estimates, Crop Science Unit Boosts Sales
• 15:18 Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y
• 15:50 RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus
• 15:48 BDTX Shares Gain 11% in a Week: Here's What You Should Know
• 15:27 ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised
• 13:40 Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
• 17:26 TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline Hurdle
• 17:17 VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings
• 16:47 Xenon Q1 Earnings Match Estimates, Pipeline Development in Focus
• 16:39 Kodiak's Q1 Loss Wider Than Expected, Pipeline Development in Focus
• 16:07 BEAM's Q1 Loss Wider Than Expected, Revenues Beat Estimates
• 16:03 PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised
• 15:10 IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%
• 14:02 Insmed's Q1 Earnings Beat, Sales Miss Estimates, Stock Tanks 23%